Systemic delivery of therapeutic viruses

Area of Science:

• Biomedical Engineering
• Gene Therapy
• Virology

Background:

• Systemic delivery of therapeutic genes or viruses is crucial for treating various diseases.
• Intravascular injection is the preferred route for achieving widespread distribution of therapeutic viruses.
• Viruses face numerous biological barriers upon intravascular administration, hindering target site delivery.

Purpose of the Study:

• To review recent advances in understanding virus tropism after systemic administration.
• To discuss the pharmacology of therapeutic viruses and factors influencing their efficacy.
• To examine how barriers affect adenoviruses and translate to other therapeutic viruses.

Main Methods:

• Literature review of recent advances in viral vector delivery.
• Analysis of mechanisms governing virus tropism and interactions within the bloodstream.
• Case study using adenoviruses as a model for therapeutic virus behavior.

Main Results:

• Systemic viral delivery is impeded by interactions with blood components, immune cells, and endothelial barriers.
• Hepatocytes and macrophages contribute to viral clearance, limiting distribution.
• Adenoviruses serve as a model to illustrate efficacy, side effects, and barrier challenges for therapeutic viruses.

Conclusions:

• Overcoming biological barriers is essential for successful systemic viral gene therapy.
• Understanding virus-host interactions informs the design of more effective viral vectors.
• Further research into viral vector pharmacology and tropism will enhance therapeutic applications.